Peringatan Keamanan

Oral, rat: LD50 = 2372 mg/kg

Demeclocycline

DB00618

small molecule approved

Deskripsi

A tetracycline analog having a 7-chloro and a 6-methyl. Because it is excreted more slowly than tetracycline, it maintains effective blood levels for longer periods of time.

Struktur Molekul 2D

Berat 464.853
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 10-17 hours
Volume Distribusi -
Klirens (Clearance) * Renal cl=35 mL/min/1.73 m2

Absorpsi

Tetracyclines are readily absorbed.

Metabolisme

Hepatic

Rute Eliminasi

Demeclocycline hydrochloride, like other tetracyclines, is concentrated in the liver and excreted into the bile where it is found in much higher concentrations than in the blood. Following a single 150 mg dose of demeclocycline hydrochloride in normal volunteers, 44% (n = 8) was excreted in urine and 13% and 46%, respectively, were excreted in feces in two patients within 96 hours as active drug.

Interaksi Makanan

3 Data
  • 1. Avoid milk and dairy products.
  • 2. Avoid multivalent ions.
  • 3. Take on an empty stomach.

Interaksi Obat

350 Data
Desmopressin The therapeutic efficacy of Desmopressin can be decreased when used in combination with Demeclocycline.
Succinylcholine The therapeutic efficacy of Succinylcholine can be increased when used in combination with Demeclocycline.
Metocurine iodide The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Demeclocycline.
Gallamine triethiodide The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Demeclocycline.
Cisatracurium Demeclocycline may increase the neuromuscular blocking activities of Cisatracurium.
Rocuronium The therapeutic efficacy of Rocuronium can be increased when used in combination with Demeclocycline.
Atracurium besylate The therapeutic efficacy of Atracurium besylate can be increased when used in combination with Demeclocycline.
Doxacurium The therapeutic efficacy of Doxacurium can be increased when used in combination with Demeclocycline.
Mivacurium The therapeutic efficacy of Mivacurium can be increased when used in combination with Demeclocycline.
Decamethonium The therapeutic efficacy of Decamethonium can be increased when used in combination with Demeclocycline.
Metocurine The therapeutic efficacy of Metocurine can be increased when used in combination with Demeclocycline.
Pancuronium The therapeutic efficacy of Pancuronium can be increased when used in combination with Demeclocycline.
Pipecuronium The therapeutic efficacy of Pipecuronium can be increased when used in combination with Demeclocycline.
Vecuronium The therapeutic efficacy of Vecuronium can be increased when used in combination with Demeclocycline.
Rapacuronium The therapeutic efficacy of Rapacuronium can be increased when used in combination with Demeclocycline.
Pyrantel The therapeutic efficacy of Pyrantel can be increased when used in combination with Demeclocycline.
Neosaxitoxin The therapeutic efficacy of Neosaxitoxin can be increased when used in combination with Demeclocycline.
Atracurium The therapeutic efficacy of Atracurium can be increased when used in combination with Demeclocycline.
Gallamine The therapeutic efficacy of Gallamine can be increased when used in combination with Demeclocycline.
Alcuronium The therapeutic efficacy of Alcuronium can be increased when used in combination with Demeclocycline.
Tubocurarine The therapeutic efficacy of Tubocurarine can be increased when used in combination with Demeclocycline.
Bismuth subsalicylate The serum concentration of Demeclocycline can be decreased when it is combined with Bismuth subsalicylate.
Mecamylamine Demeclocycline may increase the neuromuscular blocking activities of Mecamylamine.
Mipomersen Demeclocycline may increase the hepatotoxic activities of Mipomersen.
Quinapril Quinapril can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sucralfate Sucralfate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron sucrose The serum concentration of Demeclocycline can be decreased when it is combined with Iron sucrose.
Flucloxacillin The therapeutic efficacy of Flucloxacillin can be decreased when used in combination with Demeclocycline.
Piperacillin The therapeutic efficacy of Piperacillin can be decreased when used in combination with Demeclocycline.
Ampicillin The therapeutic efficacy of Ampicillin can be decreased when used in combination with Demeclocycline.
Phenoxymethylpenicillin The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Demeclocycline.
Dicloxacillin The therapeutic efficacy of Dicloxacillin can be decreased when used in combination with Demeclocycline.
Carbenicillin The therapeutic efficacy of Carbenicillin can be decreased when used in combination with Demeclocycline.
Nafcillin The therapeutic efficacy of Nafcillin can be decreased when used in combination with Demeclocycline.
Oxacillin The therapeutic efficacy of Oxacillin can be decreased when used in combination with Demeclocycline.
Hetacillin The therapeutic efficacy of Hetacillin can be decreased when used in combination with Demeclocycline.
Benzylpenicilloyl polylysine The therapeutic efficacy of Benzylpenicilloyl polylysine can be decreased when used in combination with Demeclocycline.
Mezlocillin The therapeutic efficacy of Mezlocillin can be decreased when used in combination with Demeclocycline.
Cyclacillin The therapeutic efficacy of Cyclacillin can be decreased when used in combination with Demeclocycline.
Benzylpenicillin The therapeutic efficacy of Benzylpenicillin can be decreased when used in combination with Demeclocycline.
Amoxicillin The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Demeclocycline.
Azlocillin The therapeutic efficacy of Azlocillin can be decreased when used in combination with Demeclocycline.
Cloxacillin The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Demeclocycline.
Amdinocillin The therapeutic efficacy of Amdinocillin can be decreased when used in combination with Demeclocycline.
Bacampicillin The therapeutic efficacy of Bacampicillin can be decreased when used in combination with Demeclocycline.
Meticillin The therapeutic efficacy of Meticillin can be decreased when used in combination with Demeclocycline.
Pivampicillin The therapeutic efficacy of Pivampicillin can be decreased when used in combination with Demeclocycline.
Pivmecillinam The therapeutic efficacy of Pivmecillinam can be decreased when used in combination with Demeclocycline.
Ticarcillin The therapeutic efficacy of Ticarcillin can be decreased when used in combination with Demeclocycline.
Azidocillin The therapeutic efficacy of Azidocillin can be decreased when used in combination with Demeclocycline.
Carindacillin The therapeutic efficacy of Carindacillin can be decreased when used in combination with Demeclocycline.
Procaine benzylpenicillin The therapeutic efficacy of Procaine benzylpenicillin can be decreased when used in combination with Demeclocycline.
Sultamicillin The therapeutic efficacy of Sultamicillin can be decreased when used in combination with Demeclocycline.
Temocillin The therapeutic efficacy of Temocillin can be decreased when used in combination with Demeclocycline.
Epicillin The therapeutic efficacy of Epicillin can be decreased when used in combination with Demeclocycline.
Pheneticillin The therapeutic efficacy of Pheneticillin can be decreased when used in combination with Demeclocycline.
Carfecillin The therapeutic efficacy of Carfecillin can be decreased when used in combination with Demeclocycline.
Propicillin The therapeutic efficacy of Propicillin can be decreased when used in combination with Demeclocycline.
Clometocillin The therapeutic efficacy of Clometocillin can be decreased when used in combination with Demeclocycline.
Sulbenicillin The therapeutic efficacy of Sulbenicillin can be decreased when used in combination with Demeclocycline.
Penamecillin The therapeutic efficacy of Penamecillin can be decreased when used in combination with Demeclocycline.
Talampicillin The therapeutic efficacy of Talampicillin can be decreased when used in combination with Demeclocycline.
Aspoxicillin The therapeutic efficacy of Aspoxicillin can be decreased when used in combination with Demeclocycline.
Metampicillin The therapeutic efficacy of Metampicillin can be decreased when used in combination with Demeclocycline.
Picosulfuric acid The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Demeclocycline.
Bismuth subcitrate potassium The serum concentration of Demeclocycline can be decreased when it is combined with Bismuth subcitrate potassium.
Strontium ranelate The serum concentration of Demeclocycline can be decreased when it is combined with Strontium ranelate.
Calcium glucoheptonate The serum concentration of Demeclocycline can be decreased when it is combined with Calcium glucoheptonate.
Calcium glubionate anhydrous The serum concentration of Demeclocycline can be decreased when it is combined with Calcium glubionate anhydrous.
Calcium gluconate The serum concentration of Demeclocycline can be decreased when it is combined with Calcium gluconate.
Calcium citrate The serum concentration of Demeclocycline can be decreased when it is combined with Calcium citrate.
Calcium Phosphate The serum concentration of Demeclocycline can be decreased when it is combined with Calcium Phosphate.
Calcium lactate The serum concentration of Demeclocycline can be decreased when it is combined with Calcium lactate.
Calcium lactate gluconate The serum concentration of Demeclocycline can be decreased when it is combined with Calcium lactate gluconate.
Calcium pangamate The serum concentration of Demeclocycline can be decreased when it is combined with Calcium pangamate.
Calcium levulinate The serum concentration of Demeclocycline can be decreased when it is combined with Calcium levulinate.
Calcium acetate The serum concentration of Demeclocycline can be decreased when it is combined with Calcium acetate.
Calcium chloride The serum concentration of Demeclocycline can be decreased when it is combined with Calcium chloride.
Calcium The serum concentration of Demeclocycline can be decreased when it is combined with Calcium.
Calcium cation The serum concentration of Demeclocycline can be decreased when it is combined with Calcium cation.
Calcium polycarbophil The serum concentration of Demeclocycline can be decreased when it is combined with Calcium polycarbophil.
Colestipol Colestipol can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colesevelam Colesevelam can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cholestyramine Cholestyramine can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sevelamer Sevelamer can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium sulfate Magnesium sulfate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium salicylate Magnesium salicylate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium chloride Magnesium chloride can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium citrate Magnesium citrate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium aspartate Magnesium aspartate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium gluconate Magnesium gluconate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium orotate Magnesium orotate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium levulinate Magnesium levulinate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium lactate Magnesium lactate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium carbonate Calcium carbonate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium oxide Magnesium oxide can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magaldrate Magaldrate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium hydroxide Magnesium hydroxide can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium trisilicate Magnesium trisilicate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium carbonate Magnesium carbonate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.

Target Protein

30S ribosomal protein
Vasopressin V2 receptor AVPR2

Referensi & Sumber

Synthesis reference: McCormick, J.R.D., Hirsch, U., Jensen, E.R. and Sjolander, N.O.; U.S. Patent 2,878,289; March 17, 1959; assigned to American Cyanamid Company. Szumski, S.A.; U.S. Patent 3,012,946; December 12,1961; assigned to American Cyanamid Company. Goodman, J.J. and Matrishin, M.; U.S. Patent 3,019,172; assigned to American Cyanamid Company. Goodman, J.J.; U.S. Patent 3,050,446; August 21, 1962; assigned to American Cyanamid Company. Neidleman, S. L.; US. Patent 3,154,476; October 27,1964; assigned to Olin Mathieson Chemical Corporation.
Artikel (PubMed)
  • PMID: 170519
    De Troyer A, Demanet JC: Correction of antidiuresis by demeclocycline. N Engl J Med. 1975 Oct 30;293(18):915-8.

Contoh Produk & Brand

Produk: 34 • International brands: 2
Produk
  • Declomycin
    Tablet • 150 mg • Oral • Canada • Approved
  • Declomycin - Tab 300mg
    Tablet • 300 mg • Oral • Canada • Approved
  • Declomycin Tab 150mg
    Tablet • 150 mg / tab • Oral • Canada • Approved
  • Declomycin Tab 300mg
    Tablet • 300 mg / tab • Oral • Canada • Approved
  • Demeclocycline Hydrochloride
    Tablet • 150 mg/1 • Oral • US • Generic • Approved
  • Demeclocycline Hydrochloride
    Tablet, film coated • 150 mg/1 • Oral • US • Generic • Approved
  • Demeclocycline Hydrochloride
    Tablet, film coated • 300 mg/1 • Oral • US • Generic • Approved
  • Demeclocycline Hydrochloride
    Tablet, film coated • 150 mg/1 • Oral • US • Generic • Approved
Menampilkan 8 dari 34 produk.
International Brands
  • Declostatin
  • Ledermycin — Takeda

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul